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Abstract 24 
 25 
Clostridium difficile is a major cause of antibiotic induced diarrhoea worldwide, 26 
responsible for significant annual mortalities and represents a considerable economic 27 
burden on healthcare systems. The two main C. difficile virulence factors are toxins A and 28 
B. Isogenic toxin B mutants of two independently isolated erythromycin-sensitive 29 
derivatives (630E and 630Δerm) of strain 630 were previously shown to exhibit 30 
substantively different phenotypes.  Compared to 630, strain 630E and its progeny grow 31 
slower, achieve lower final cell densities, exhibit a reduced capacity for spore-formation, 32 
produce lower levels of toxin and are less virulent in the hamster infection model. By the 33 
same measures, strain 630Δerm and its derivatives more closely mirror the behaviour of 34 
630. Genome sequencing revealed that 630Δerm had acquired seven unique Single 35 
Nucleotide Polymorphisms (SNPs) compared to 630 and 630E, while 630E had nine SNPs 36 
and a DNA inversion not found in the other two strains.  The relatively large number of 37 
mutations meant that the identification of those responsible for the altered properties of 38 
630E was not possible, despite the restoration of three mutations to wildtype by allelic 39 
exchange and comparative RNAseq analysis of all three strains. The latter analysis revealed 40 
large differences in gene expression between the three strains, explaining in part why no 41 
single SNP could restore the phenotypic differences. Our findings suggest that strain 42 
630∆erm should be favoured over 630E as a surrogate for 630 in genetic-based studies.  43 
They also underline the importance of effective strain curation and the need to genome re-44 
sequence master seed banks wherever possible.   45 
 46 
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Introduction 47 
 48 
Clostridium difficile is a Gram-positive, anaerobic spore-forming bacterium capable of 49 
causing a range of diseases from mild diarrhoea to potentially fatal toxic 50 
pseudomembranous colitis. The toxigenic effects of C. difficile are caused by the activities 51 
of two large, glucosylating toxins. The two toxins are 308kDa (toxin A) and 270kDa (toxin B) 52 
in size 1-3 and are encoded by the chromosomally located genes tcdA and tcdB, 53 
respectively. Both are cytopathic to cultured cells due to disruption of the cytoskeleton, 54 
although TcdB is thought to be up to 1000-times more potent.1 Historically, toxin A was 55 
regarded as the main causative agent of the symptoms of C. difficile infection (CDI). Pivotal 56 
data was provided by Lyerly et al.4 who were only able to detect disease when hamsters 57 
were subject to intragastric challenge with purified TcdA alone and not with TcdB. The 58 
latter could, however, cause disease symptoms if prior damage to the mucosa had been 59 
inflicted by co-administration of sub-lethal concentrations of toxin A. Furthermore, co-60 
administration of both toxins led to more severe disease symptoms. To accommodate 61 
these data, it was generally accepted that both toxins acted in concert to bring about 62 
disease symptoms, with toxin A leading to the initial damage to the colon allowing the 63 
subsequent access of the more potent toxin B. 64 
During the 1990’s C. difficile strains were isolated from symptomatic patients that only 65 
produced toxin B (A-B+)5, 6. These findings suggested that toxin B, at least in certain strains, 66 
is capable of causing disease without the help of toxin A. It has been reported since that 67 
toxin B, in A-B+ strains, is modified and seems to be an evolutionary hybrid of C. difficile 68 
toxin B and Clostridium sordellii lethal toxin.7 69 
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With the development of genetic systems, assumptions of the relative importance of 70 
the two toxins could be tested through the creation, and in vivo assay, of isogenic mutants 71 
in which production of either toxin had been ablated. Initial findings made by Lyras et al.8 72 
appeared to turn the perceived view on its head, through the demonstration that a tcdA 73 
mutant producing TcdB alone (A-B+) was capable of causing disease in the hamster model 74 
while a tcdB mutant producing only TcdA (A+B-) did not.  These data were, however, 75 
almost immediately questioned by a second study conducted in the Minton laboratory 9 76 
showing that both tcdA and tcdB C. difficile mutants, and therefore TcdA and TcdB alone, 77 
were independently capable of causing disease. Interestingly, a strain has recently10 beren 78 
isolated from a clinical case of CDI, that only produces TcdA (A+B-) 79 
The possible reasons for the observed difference in outcomes of the two studies have 80 
been discussed previously. 11 Both studies agree on the virulence potential of toxin B, but 81 
uncertainties remain about the different outcomes concerning the effects of toxin A. In the 82 
work presented here, we have hence focused on comparisons of the parental strains and 83 
the strains only producing toxin A (A+B-). In essence, both sets of mutants were generated 84 
by insertional inactivation of the toxin genes of the C. difficile strain 630 12 and, once 85 
created, were tested in the hamster infection model. However, in order to implement the 86 
available gene tools in strain 630 (at the time the only strain for which a genome sequence 87 
was available), it was necessary to first isolate a variant that had become sensitive to 88 
erythromycin, thereby allowing the use of an ermB gene as a selective, genetic marker. 89 
Both studies used such an erythromycin-sensitive derivative of strain 630, but they were 90 
independently isolated.  In our study (Minton group), 9 we used the strain 630Δerm, 91 
isolated in the Mullany laboratory (UCL, London, UK) after 30 repeated subcultures of 92 
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strain 630 in non-selective media. 13 In parallel, the Rood laboratory (Monash, Australia) 93 
independently isolated the erythromycin sensitive strain JIR8094 (also referred to as 630E), 94 
14 through an undisclosed number of subcultures of strain 630 in non-selective media. Both 95 
strains are reported to possess the same specific deletion of ermB. 13, 14 96 
We have previously hypothesised 11 that the different outcomes of the two studies 8, 9 97 
are a direct consequence of the use of the two, independently isolated erythromycin-98 
sensitive strains, 630Δerm and 630E. We suggested that during repeated subculture, 99 
ancillary mutations arose which impacted on the virulence potential of one or other of the 100 
two strains in the presence of different toxin gene alleles. In the current piece of work, we 101 
have set out to test this hypothesis. We have undertaken side-by-side comparisons of 102 
630Δerm and 630E, and the A+B- mutant derivatives, in a variety of assays to establish 103 
phenotypic differences. In parallel, we have determined the genome sequences of the 104 
various strains used in the two studies. 8, 9 Then, we have used our newly developed allelic 105 
exchange methodologies 15 to correct a number of SNPs in strain 630E back to wild-type 106 
and assessed the consequences. Furthermore we have performed RNAseq experiments 107 
comparing the transcriptome of 630, 630Δerm and 630E at three different time points. The 108 
RNA data were related to the whole genome data to draw our final conclusions. 109 
 110 
Results 111 
Generation of a ClosTron insertion in tcdB of 630E 112 
Although considered unlikely, the possibility existed that mutants made by the 113 
insertion of a plasmid element carrying ermB 14 might behave differently to an equivalent 114 
mutant made by the insertion of a group II intron incorporating ermB. 16 Our initial step 115 
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was, therefore, to create a tcdB mutant of strain 630E using ClosTron technology. 116 
Accordingly, the ClosTron plasmid pMTL007C-E2::Cdi-tcdB-1511a that had previously been 117 
used to generate strain 630∆erm A+B- 9 was used to create an equivalent mutant in strain 118 
630E as described. 9 The resulting mutant, 630E A+B-CT, was verified by PCR, Sanger 119 
sequencing and shown by Southern blot to carry a single group II intron insertion (Fig. 120 
S1A). Parental strains, original A+B- mutants and the newly obtained mutant were tested 121 
for production of toxin A in a Western blot (Fig. S1B). As expected all strains produced 122 
toxin A. 123 
 124 
Phenotypic characterisation of strains 125 
In order to establish whether all strains were phenotypically identical a range of assays 126 
were performed, comparing growth, motility and spore properties. An analysis of growth 127 
rates using the procedure described in Materials and Methods showed that strain 630∆erm 128 
and derivatives grew to the highest optical density, closely followed by strain 630 and 129 
630E, and derivatives thereof (Fig. 1A and 1B). The data clearly demonstrated that strain 130 
630∆erm and its 630∆erm A+B- derivative had relatively higher growth rates and achieved 131 
higher optical densities (p < 0.0001, unpaired t-test at 24 h) than strain 630E and its 132 
derivatives, with strain 630E A+B-CT growing the least (Fig. 1B). It was also apparent, 133 
shown by plate motility assay (Fig. 2), that strains 630 and 630∆erm were motile, while 134 
630E was not. Only 630 and 630∆erm, but not 630E, form pseudopod-like structures, 135 
which are characteristic for swarming motility in bacteria.   136 
Following the protocols of Burns et al, 17 comparative differences in the numbers of 137 
colony forming units (CFUs) obtained following heat shock were assessed between the 138 
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strains, as a crude estimate of spore formation. 18 On this basis, strains 630∆erm and 139 
630∆erm A+B- produced a greater numbers of spores than 630E and its derivatives, which 140 
failed to produce any spores until 72 h. The total number of CFU/mL at this time point was 141 
103 times fewer than that obtained with 630∆erm or 630∆erm A+B- (Fig. 3A). Interestingly 142 
parental strain 630 produced very few spores before 72 h, but spore counts increased from 143 
72 h onwards and reached similar levels to strains 630∆erm and 630∆erm A+B- by the end 144 
of the experiment. The reduction in spore formation may in part be due to the observed 145 
reduction in OD as the 630E strains enter stationary phase, which might also explain their 146 
predilection to flocculate. Indeed comparing percentage sporulation (relative to vegetative 147 
cell count), confirmed the observation that 630∆erm and 630∆erm A+B- have a higher 148 
sporulation frequency than both 630E (and derivatives) and strain 630. 149 
The germination of the 630E strains was also comparatively reduced and did not reach 150 
the same level as that of 630∆erm and its progeny. At the last time point (240 min) strains 151 
630E and 630E A+B- reach the same level of CFU/ml as strain 630. The observed delay 152 
could be due to the previously observed reduced cell growth of the 630E strains (Fig. 3B).   153 
 154 
Toxin Production  155 
Measurements of the amounts of toxin being produced by 630E and 630∆erm and 156 
their derivatives were undertaken using both the C. DIFFICILE TOX A/B II™ ELISA assay kit 157 
from TechLab, measuring toxin A and B, and kits from TGCbiomics, specifically measuring 158 
either only toxin A or only toxin B. The results of the 72 h time point are shown in Fig. 4.  159 
As shown in Fig. 4A, toxin production of 630, 630∆erm or 630∆erm A+B- clustered 160 
together, as did toxin production of 630E, 630E A+B- or 630E A+B- CT with the latter three 161 
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showing no statistical differences between them (P >0.05, one-way ANOVA with Fisher’s 162 
LSD test). There was, however, a statistically significant difference between the first three 163 
strains (630, 630∆erm or 630∆erm A+B-) and the second set of three strains (630E, 630E 164 
A+B- or 630E A+B- CT) (P < 0.0001). The C. DIFFICILE TOX A/B II™ ELISA does not 165 
differentiate between toxin A and B. In order to be able to quantify each toxin, the kits 166 
from TGCbiomics were used (Fig. 4B and 4C). The toxin A ELISA showed significantly higher 167 
production in strain 630Δerm compared to 630E (p<0.0016) and also confirmed the 168 
previous observations that strains with impaired tcdB, produce more toxin A 8, 9 (Fig. 4B). 169 
No toxin B production was seen, as expected, in the tcdB-mutants. Strains 630 and 170 
630Δerm, however, both produced significantly more toxin B than 630E (p<0.0001) (Fig. 171 
4C). 172 
 173 
Whole genome sequencing 174 
To establish whether strains 630E and 630Δerm, and derivatives, contained any 175 
additional changes to the ermB gene deletion, relative to the parent strain 630, the 176 
following strains were sequenced using Next Generation Sequencing platforms: 630E A+B-, 177 
630E A+B- CT on Illumina HiSeq (GATC, Germany) and 630Δerm A-B on a Roche 454 178 
(Deepseq, University of Nottingham, UK) and the data compared to the published genome 179 
of the parental strain 630 12 and previously sequenced 630ΔermΔpyrE. 19 We used a 180 
frequency of 70% as a cut-off for SNP calling and found multiple SNPs, InDels and other 181 
minor changes, both common and unique to 630, 630E and 630Δerm. In total, two SNPs in 182 
coding regions with non-synonymous changes were found that were common to all three 183 
strains (in CD630_11900, encoding an acyl-CoA N-acyltransferase where SNP changes 184 
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phenylalanine133 to leucine and in CD630_13880, a pseudo gene where a frameshift is 185 
introduced). In addition to these, we found in both 630 and 630Δerm strains three SNPs 186 
(two in intergenic regions and one in a coding region of CD630_2667, encoding the BC 187 
domain of a glucose PTS, changing valine228 to isoleucine). 630Δerm had seven unique 188 
changes compared to 630 and 630E (including six non-synonymous SNPs in coding 189 
regions), while 630E had eleven SNPs (with nine non-synonymous SNPs in coding regions) 190 
not found in the other two strains. SNPs were confirmed by Sanger sequencing and 191 
thereafter by RNAseq data (see below). Indeed, the SNPs found in the DNA-seq data were 192 
validated by using the RNA-seq sequence reads mapped on the genome sequence with 193 
Bowtie2 20 with each position being checked using Tablet 21. A complete list of SNPs and 194 
other small changes are indicated in Table 1 and in supplementary Table S1. During the 195 
preparation of this manuscript a new sequence of 630 was published by Riedel et al. 22. We 196 
incorporated their data into Table 1 (and Table S1). Overall this new sequence shows very 197 
few disparities to the original one. However two SNPs found in our data were attributed to 198 
mistakes in the original sequence (in CD630_17670 and CD630_31561). Another paper was 199 
recently published by van Eijk et al., 23 resequencing 630Δerm. Overall there are very few 200 
discrepancies between their data and our findings, confirming the quality of both data sets. 201 
We have incorporated their findings into Table S1. 202 
It may be assumed, that during the repeated subculture of strain 630 undertaken in 203 
the Mullany 13 and Rood 14 laboratories, sub-populations within the culture were isolated 204 
carrying SNPs. However, it seems improbable that the two SNPs (Table 1), common to all 205 
three strains, arose independently. Rather we hypothesise that these SNPs might be 206 
sequencing mistakes. This theory gains weight through the new sequencing data by Riedel 207 
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et al. 22. Two SNP changes which we identified originally between the published 630 208 
sequence and our data were confirmed by Riedel et al to also be the sequence of their 630 209 
seed stock. Unfortunately the genome announcement 22 does not state the exact source of 210 
their 630 strain. As mentioned above another three SNPs were only found in 630 and 211 
630Δerm, two of these are in intergenic regions which showed no expression in our 212 
RNAseq experiment, and the third is located in a PTS gene in 630 and 630Δerm (position 213 
3080703, Val228Ile). Rather than having occurred independently it is more likely that these 214 
SNPs arose in the Mullany laboratory, subsequent to provision of chromosomal DNA to the 215 
Sanger Centre for determination of the 630 genome sequence 12, and before the strain 630 216 
was passaged to obtain 630Δerm. At the time, C. difficile strains in the Mullany laboratory 217 
were routinely stored at 4°C as Robertson’s Cooked Meat stocks, as opposed to being 218 
frozen at -80°C in 10% glycerol (A.R. Roberts, personal communication). On this basis, the 219 
traditional microbiological practice of using Robertson’s Cooked Meat to curate strains 220 
might not be ideal as strains are not entirely dormant and genome changes can occur over 221 
time. The SNPs that were found to be unique to 630Δerm and 630E (n=8 and n=11, 222 
respectively) can be assumed to have been accrued at some point after the two 630 223 
populations diverged, that is when the strain was sent to the Rood laboratory. It is most 224 
likely, although not certain, that the majority, if not all of the strain-specific SNPs arose 225 
during the repeated subculture experiments undertaken to isolate the ermB deletion 226 
strains 630E and 630Δerm. 227 
Changes specific to 630Δerm include SNPs in three intergenic regions, which all have 228 
been determined with a coverage of over 150 and 100 % frequency (see Table 1). The 229 
other five changes comprise four non-synonymous SNPs and an insertion. The insertion 230 
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has previously been reported by Rosenbusch et al.24 and was confirmed by van Eijk et al. 23 231 
and is an 18 bp duplication in spo0A, the master regulator of sporulation. This insertion 232 
might be responsible for the reduced sporulation frequency seen in strain 630 and also in 233 
630E and derivatives, which do not carry this duplication (which does not have this 234 
duplication) (Fig. 3A). The SNPs have been found in the following genes: CD630_08260, 235 
encoding a ferric uptake regulator (perR homologue) (Thr41Ala); CD630_19070, encoding 236 
an alcohol dehydrogenase homologue (eutG) (Gly252Glu); and CD630_35630, encoding a 237 
transcriptional regulator of the GntR family (Ala91Val).  238 
In contrast, strain 630E contains a larger number of non-synonymous SNPs including 239 
changes that result in nonsense mutations and in one case the inversion of a small 240 
segment of DNA preceding a flagella operon. We found two changes in intergenic regions, 241 
one with 100 % frequency and a coverage of 94 (position 3528736); the other at a much 242 
lower frequency (41 %), but confirmed a 150 bp inversion by Sanger sequencing in the 243 
promoter region of flgB, the first gene in a F3 flagella operon (early flagella genes). Non-244 
synonymous SNPs were found in CD630_07610, encoding a putative RNA helicase 245 
(Asp136Tyr); CD630_14040, encoding an oligopeptide transporter (Glu536Gly); 246 
CD630_20270, encoding a hydrolase (Gly373Glu); CD630_29430, encoding a phage 247 
replication protein (Asn210Asp); and CD630_33790, encoding a conjugative transposon 248 
protein (Glu63Asp). Finally, there is another SNP at position 3034953, in gene CD630_26270 249 
(Gly68Cys), encoding a conserved hypothetical protein. Interestingly the new genome 250 
sequence from Eijk et al. 23 suggested an “A” at position 3034953 in contrast to the earlier 251 
annotation suggesting “C”. The new annotation is in line with our RNAseq data (Table S1) 252 
and taken into account our sequencing data (Table 1) suggests that this is indeed a 253 
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mutation in 630E and was miss-annotated in the original sequence. In one instance the 254 
nucleotide substitution resulted in the creation of a nonsense, stop codon, and as a 255 
consequence a severe, premature truncation of the encoding protein. Thus, the stop codon 256 
introduced into CD630_12740 encoding a topoisomerase I (topA) homologue (Gln386*) 257 
truncated the protein from 695 amino acids to 385 amino acids. Conversely, in the case of 258 
the glucose PTS operon ptsG-BC, the conversion of the stop codon of ptsG-B gene 259 
(CD630_26670) to a Glu codon (*524Glu) resulted in its fusion to the coding region of the 260 
immediately downstream ptsG-C gene.   261 
Virulence testing of 630Δerm, 630E and mutants using an in vivo model  262 
In order to confirm previous data and to rule out differences in experimental set up in 263 
different laboratories, the virulence of 630E and derivatives was assessed using the 264 
hamster infection model in our laboratory (University of Nottingham) as previously 265 
described. 9  266 
Figure 5 shows the times from infection to endpoint (in days) for the hamsters 267 
infected with 630E, 630E A+B- and 630E A+B- CT. For comparative purposes data for 268 
infection with 630Δerm and 630Δerm A+B- from a previous study 9 is also included.  The 269 
latter emphasises the fact that all eight hamsters infected with strain 630Δerm were 270 
colonised and succumbed to C. difficile disease (with an average time of 3.25 days from 271 
infection to endpoint). This is in direct contrast to what is observed with 630E where of the 272 
five animals successfully infected, only three were colonised till the respective endpoints 273 
and of these, two succumbed to disease (at day two and six). Two animals lost colonisation 274 
after days 15 and 18, respectively. 275 
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In our previous study 9 seven, of the eight animals infected with 630∆erm A+B- (as also 276 
shown in Fig. 5), succumbed to disease with an average time to death of colonised 277 
hamsters being just under two days. One animal showed no signs of disease until the 278 
experimental endpoint, but was found not to have been colonised. Here of the 11 animals 279 
infected with the equivalent mutant of strain 630E (630E A+B-), only two animals 280 
succumbed to CDI (on day two and nine). Four animals in this group were never colonised, 281 
one lost colonisation after day three and the others were colonised till endpoint. Six 282 
animals were infected with 630E A+B- CT, and of these two hamsters developed infection 283 
(day three and five). Two of the surviving animals lost colonisation after day 15 and 18 284 
respectively. (Fig. 5 and Table S2).    285 
The difference between the average time to death of all hamsters administered 286 
630∆erm and 630∆erm A+B- was found not to be statistically significant (one-way ANOVA, 287 
p=0.5355) (results from Kuehne et al. 9). Similarly, the differences between the average 288 
times to death of all animals administered 630E, 630E A+B- and 630E A+B- CT was not 289 
statistically significant (one-way ANOVA, p=0.8919). In contrast, the difference between 290 
the 630∆erm strain (and derivative) and the 630E strain (and derivatives) was statistically 291 
significant (one-way ANOVA, p>0.0001).   292 
 293 
Correction of SNPs in strain 630E 294 
In view of the large number of SNPs present in strain 630E, it was impractical to 295 
change them all back to the 630 parental sequence. We therefore selected just three 296 
specific mutations present in 630E and converted them back to the sequence present in 297 
the parental strain, 630.    298 
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Our principal target was to remove the stop codon from within the topoisomerase I 299 
gene, CD630_12740, as this enzyme plays a central role in the regulation of DNA negative 300 
supercoiling and its inactivation is likely to result in extensive pleiotropic effects. Indeed, in 301 
some bacteria its inactivation is lethal. 25-27 Moreover, bacterial genes related to 302 
pathogenesis and virulence have been shown to be sensitive to topA mutation in E. coli, 28 303 
S. flexneri, 29 Yersinia enterocolitica 30 and Salmonella. 31 We therefore converted the “T” 304 
nucleotide at position 1480649 in 630E back to an “A” nucleotide, thereby removing the 305 
nonsense stop codon and allowing the production of full length native topoisomerase 306 
enzyme.   307 
As a second target we elected to correct the inversion of DNA upstream of the F3 308 
flagella operon. As strain 630E is non-motile, and as the inverted region encompasses the 309 
non-coding region immediately upstream of the flgB gene, it is likely to have disrupted the 310 
promoter responsible for both flgB expression and the genes in the downstream operon. 311 
The inversion is therefore likely to be the principal cause of the loss of motility in 630E. 312 
Furthermore, factors affecting flagella expression can also influence toxin expression 313 
levels. 32, 33   314 
Finally, we sought to correct the fusion of the two PTS components ptsG-B and ptsG-C, 315 
by resurrection of the stop codon of ptsG-B through the conversion of the “C” nucleotide 316 
at position 3079815 back to an “A” nucleotide. As glucose is known to affect toxin 317 
production, through catabolite repression, 34, 35 it was reasoned that this particular SNP 318 
could be affecting toxin expression, and therefore virulence.  319 
The plasmids carrying the 630 wildtype alleles necessary for the correction of the 320 
three targeted SNPs were assembled as described in Materials and Methods and then used 321 
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to effect the replacement of the 630E mutant alleles by allelic exchange. 15  To verify that 322 
the mutant clones obtained were correct, each targeted region was amplified by PCR using 323 
appropriate oligonucleotide primers and the DNA fragments obtained subjected to Sanger 324 
sequencing on both DNA strands. In every case, clones carrying the desired ‘corrected’ 325 
sequence were obtained. The new strains were named after the genes or regions that 326 
were corrected, namely 630E_topA, 630E_CD2667 and 630E_flgB, respectively.  327 
To assess the effects of the changes on the characteristics of the mutant strains, 328 
growth rate, sporulation and germination, motility, and in vitro cytotoxicity and toxin 329 
production (ELISA) were measured. None of the three corrected mutants exhibited any 330 
difference in growth rate compared to the parental strain 630E (data not shown). Similarly, 331 
sporulation and germination remained unaffected (data not shown). Toxicity testing 332 
revealed no difference to 630E using the C. DIFFICILE TOX A/B II™ ELISA assay kit from 333 
TechLab (Fig. 4A). To quantify toxin A and toxin B individually the ELISA kits from 334 
TGCbiomics were used to assay 630E_topA and 630E_CD2667 (Fig. 4B). No differences 335 
were measured for toxin A, but the strain 630E_topA showed significantly higher levels of 336 
toxin B than the parental strain 630E. 337 
 338 
Transcriptomic comparison of 630, 630∆erm and 630E 339 
RNA was extracted from strains 630, 630∆erm and 630E at 6, 14 and 24 h and used in 340 
an RNAseq experiment as described in Materials and Methods. The Principal Component 341 
Analysis (PCA) (Fig. 6) showed that strain 630∆erm and 630E are closely correlated on a 342 
transcriptional level which is significantly separated from 630. While this result implies that 343 
both strains are fundamentally different to the parental strain, it does not indicate that the 344 
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differences to 630 are the same for both strains. The analysis depicted by the Venn 345 
diagram (Fig. 7) confirms the results of the PCA, showing that the majority of differentially 346 
expressed genes are observed comparing 630∆erm and 630E to 630. From a total of 1337 347 
differentially expressed genes (Table S3 contains all the genes differentially expressed 348 
along the growth and also comparisons between the strains), only 139 were common 349 
between all three strains. A total of 345 were common between 630E and 630∆erm, 60 350 
were common between 630 and 630∆erm and 58 were common between 630 and 630E. 351 
Most of the 345 genes differentially expressed in both, 630∆erm and 630E, were either 352 
up or down-regulated in the same way highlighting again how distinct the two strains are 353 
from the parental strain 630 (Table S3). In TY medium used for the transcriptomic 354 
experiments, known as a non-optimal for spore production, a total of 44 sporulation genes 355 
were differentially expressed in both 630∆erm and 630E, and all of these were 356 
downregulated at 14 and 24 h compared to 6 h. No further differentially expressed 357 
sporulation genes appeared in 630∆erm, however, our analysis showed a further 22 358 
sporulation genes, of which 21 were downregulated, in 630E. Amongst these was the 359 
master regulator of sporulation spo0A. Nine genes classed as stress-related are 360 
differentially expressed in all three strains (five upregulated), with a further three in 630 361 
(all upregulated), seven in 630∆erm (four upregulated) and 16 in 630E (11 upregulated). 362 
Nine genes related to secretion are down regulated in 630E and one gene related to type 363 
IV pili is upregulated. In comparison only one secretion gene (putative pilus assembly 364 
ATPase) is differentially expressed only in 630∆erm (down regulated) and none in 630. 365 
Metabolism is also highly differentially regulated in the three strains. 90 genes were 366 
uniquely, differentially expressed in 630E, 50 in 630∆erm and 30 in 630. In particular the 367 
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amino acid metabolism stands out for 630E with the majority of genes being 368 
downregulated. (Table S3). 369 
RNAseq data can be used to independently corroborate genome re-sequencing data.  370 
Thus, it was apparent that those changes identified by CLC Bio as being present with a 371 
frequency of 70% or less, except for CD630_20102, were not real accordingly to the 372 
RNAseq analysis (Table S1). This increases the confidence in disregarding changes 373 
identified by NGS with a low frequency. In most cases, the SNPs and Indels identified by 374 
NGS were confirmed by the RNAseq analysis, with the following exceptions: for SNPs in 375 
630E we found two disagreements notably in CD630_33790 and CD630_29430, which both 376 
had 100 % frequency and a high coverage (around 200 reads) in the DNA sequence 377 
analysis, but only low coverage in the RNAseq experiment.  Due to the low coverage of 378 
these regions during the RNAseq experiment, which is indicative of low or no expression 379 
under the examined conditions, a sequencing error cannot be excluded. For the SNP in 380 
CD630_12740 the RNA coverage corroborated the genomic data for 630E, but was in 381 
disagreement with the genomic data for 630 and 630∆erm. For three SNPs in 630∆erm 382 
similar scenarios were observed. CD630_19070 had very low RNA coverage, CD630_35650 383 
showed ambiguous RNA data with low coverage for 630E. CD630_08260, the perR 384 
homologue, had convincing DNA data, with frequencies of 98-100 % and coverage of at 385 
least a 100 which was corroborated for 630∆erm by RNAseq coverage.  386 
In terms of actual expression data (Table S1), CD630_07610 (the RNA helicase), 387 
CD630_14040 (oligopeptide transporter), CD630_20270 (hydrolase) and CD630_29430 388 
(phage replication protein) all showed differential expression in 630E compared to the 389 
other two strains, with the first two showing reduced expression and the latter two an 390 
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increase.  CD630_29430, however, also showed an increase in expression in 630 at the 391 
later time point. Changes in CD630_26670 in 630∆erm and 630E both seem to lead to 392 
severely reduced expression. CD630_12740 (topA) only showed differential expression at 393 
24 h in 630∆erm and CD630_12140 (spo0A) expression was severely reduced in 630E. 394 
 395 
Discussion 396 
Previously, two studies 8,9 have attempted to use isogenic mutants defective in the 397 
production of either toxin A or toxin B to determine the relative importance of these two 398 
virulence factors in CDI using the hamster infection model. However, despite generating 399 
essentially equivalent A+B-insertion mutants in ostensibly the same strain of C. difficile 400 
(630), contradictory outcomes were obtained in terms of the importance of toxin A. Thus, 401 
a tcdB mutant created in the one study 8 producing only TcdA did not cause disease in the 402 
hamster, whereas the equivalent ClosTron mutant made in our laboratory (Minton group) 9 403 
remained virulent. The work undertaken here has provided compelling evidence that the 404 
reason for the observed conundrum resides in the use of two different erythromycin-405 
sensitive derivatives of strain 630.  406 
Here we have shown that both erythromycin-sensitive derivatives, 630E 14 and 407 
630∆erm 13 carry a significant number of SNPs compared to the published sequence. 408 
Moreover, it is clear that whilst the phenotypic properties of 630∆erm and its mutant 409 
derivatives closely resemble that of the parent strain 630, strain 630E and its progeny 410 
exhibit substantive differences. Thus, whereas latter strains exhibit reduced growth rates, 411 
are less proficient in spore formation and are non-motile, 630∆erm strains mirror the 412 
behaviour of the 630 parental strain with respect to these phenotypes. Furthermore, 630E 413 
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strains produce reduced amounts of toxin and both struggle to colonise hamsters, and 414 
once colonised, animals are less likely to succumb to disease. In short, 630E and its 415 
derivatives (i.e., 630E A-B+ and 630E A+B- CT) are less virulent than 630∆erm and its 416 
mutant counterparts (i.e., 630∆erm A+B-).    417 
The altered properties of 630E and its derivatives are undoubtedly a consequence of 418 
the observed SNPs. However, the substantive number of changes involved makes it 419 
difficult to assign any particular SNP to a specific alteration in the observed phenotype, 420 
particularly as a combination of mutagenic changes could be responsible. Whilst it is now 421 
possible to make precise changes to the genome using allelic exchange methodologies 15 it 422 
is not practically feasible to make all of the sequential rational changes needed to 423 
definitively identify the mutation(s) responsible for a particular phenotype. As such, we 424 
only corrected three specific SNPs that we reasoned may be making a significant 425 
contribution. The outcomes of these experiments only emphasised the difficulty of such an 426 
undertaking, and served to highlight the dangers involved in making assumptions. Thus, 427 
whilst it seemed reasonable to assume that the DNA inversion within the promoter region 428 
of the flagella operon was likely to have caused the observed non-motile phenotype, this 429 
surprisingly proved not to be the case. Re-inversion of the 150 bp region failed to restore 430 
motility. Clearly other SNPs are at least partly responsible for the observed lack of motility. 431 
Singling out any other SNP as the culprit would in the absence of experimental evidence be 432 
counterproductive. 433 
Equally negative was the observed outcome of correcting the mutation in 434 
CD630_12740 that results in a truncation of the encoded topoisomerase I enzyme. Given 435 
this enzyme controls DNA supercoiling, and given that its mutation in certain bacteria is 436 
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either a lethal event 25-27 and/or is involved in the regulation of virulence factors, 28-30 it 437 
seemed likely that its presence would result in pleiotropic effects that could have 438 
contributed to the observed phenotypic changes. However, its correction, with the 439 
exception of a measurable increase in toxin B levels, seemingly had no effects on the 440 
behaviour of the strain, at least for those properties measured. The reasons are not clear. 441 
In other bacteria, mutations of topA are only isolated if compensatory mutations arise 442 
elsewhere in the genome. 26  Whether any of the other SNPs present in 630E (eg., the RNA 443 
helicase mutation) are negating the effects of the TopA truncation is currently unknown.   444 
To understand the differences observed further, we analysed the transcriptome of 445 
630, 630∆erm and 630E, comparing expression at 6 h to 14 h and to 24 h (Table S3). The 446 
data corroborated the phenotypic analysis, showing vastly different transcriptomes for all 447 
three strains. While 630E and 630∆erm cluster together in the PCA (Fig. 6), this only 448 
highlights how different the two strains really are from the progenitor. The analysis clearly 449 
shows that the three strains are very different from each other and also serves as an 450 
explanation as to why the change of a single SNP could not restore any given phenotype. 451 
Overall 630E seems the most divergent with many genes differentially expressed involved 452 
in metabolism and regulation (Table S3). Additionally 32 genes grouped under the 453 
descriptor ‘cell factor’, many of which play a role in energy metabolism, are differentially 454 
expressed in 630E, with only six of these being upregulated. In contrast out of 19 genes in 455 
630, 11 are upregulated and, out of 10 in 630∆erm, six were upregulated. The number of 456 
genes downregulated in energy metabolism in 630E might relate to the growth differences 457 
seen between the strains.  458 
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Interestingly 22 genes involved in sporulation are differentially expressed, 21 of these 459 
downregulated, in 630E versus one in 630 and two in 630∆erm. This is consistent with the 460 
observed delay in sporulation and reduced amount of spores produced by 630E. Secretion 461 
also seems most affected in 630E, with 10 genes differentially expressed, compared to 462 
none in 630 and one in 630∆erm.  A general defect in secretion could affect the secretion 463 
of certain virulence or adhesion factors. Furthermore, 33 cell wall genes are differentially 464 
expressed in 630E (compared to 14 each in 630∆erm and 630). This may also contribute to 465 
the observed colonisation deficiencies. Mobile elements are, however, more differentially 466 
transcribed in 630 and 630∆erm (15 each) versus 630E (nine). As in many cases different 467 
pathways were affected, we propose that this could at least in part explain the different 468 
adaptability and virulence of the two strains. In both strains many regulators were 469 
differentially affected providing a further basis for the observed phenotypic variation 470 
between strains. 471 
 472 
Conclusion 473 
Our study has established that the parental strains (630E and 630∆erm) used in the 474 
two previous studies, that explored the relative roles of toxin A and toxin B in disease, 8, 9 475 
are phenotypically and genetically distinct. Here we also reveal that the three strains (630, 476 
630∆erm and 630E) have vastly different transcriptomes, which no doubt lead to the 477 
different phenotypes observed. This immense diversity also underlines our finding that by 478 
restoring just one SNP, the entire transcriptome cannot be changed. The presence of SNPs 479 
in strain 630E significantly affects its transcriptome which in turn has a significant impact 480 
on growth, sporulation and finally virulence of this strain in the hamster model of infection 481 
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under the conditions tested. Data (such as motility, toxicity and virulence) obtained with 482 
strain 630∆erm reflects more accurately the behaviour of the parent strain 630. As such, it 483 
may be concluded that 630 producing toxin A alone will cause disease in the hamster. As a 484 
consequence, toxin A should remain a target for the rational development of effective 485 
countermeasures against C. difficile.   486 
This study has also highlighted a number of issues that need to be borne in mind in the 487 
future. At a specific level, if researchers wish to undertake genetic-based studies with 488 
strain 630, then the use of strain 630∆erm should be favoured over strain 630E. At a more 489 
fundamental level, researchers need to effectively curate their strains to prevent the 490 
inadvertent isolation of SNPs. Ideally, master seed banks need to be established as frozen 491 
glycerol stocks. Moreover, the genome of the stored strain should be re-sequenced as part 492 
of the storage process whenever a strain is received from external sources, regardless of 493 
whether it has been re-sequenced in the sending laboratory.  494 
 495 
Materials and Methods 496 
Bacterial strains and routine culture conditions 497 
Bacterial strains and plasmids used in this study are listed in Table 2. E. coli was 498 
cultured aerobically at 37°C with shaking at 200 rpm in LB medium with chloramphenicol 499 
supplementation (25 μg/ml) where appropriate. C. difficile was cultured in TY (tryptose 500 
yeast) medium supplemented with thiamphenicol (15 μg/ml) where appropriate. When 501 
needed, C. difficile strains were plated on BHIS agar (Brain Heart Infusion agar [Oxoid] 502 
supplemented with 5 mg/ml yeast extract [Oxoid] and 0.1% [wt/vol] cysteine 503 
[Calbiochem]) supplemented with d-cycloserine (250 μg/ml), cefoxitin (8 μg/ml) [Oxoid] 504 
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(BHIScc). Fluorocytosine selections were carried out on C. difficile minimal medium 505 
(CDMM) as described previously.  15 All C. difficile cultures were incubated at 37°C 506 
anaerobically in an anaerobic MACS1000 workstation (Don Whitley, Yorkshire, UK).  507 
Mutant nomenclature 508 
For the sake of simplicity, C. difficile strains that carried a tcdA insertional mutant were 509 
referred to as A-, those carrying a tcdB mutant as B-, and those strains carrying a mutation 510 
in both genes as A-B-. To avoid any ambiguity, if the gene was not inactivated it was 511 
referred to as A+ or B+, as appropriate. Thus, a tcdA mutant of 630Δerm constructed using 512 
ClosTron technology as described, 9, 16 was designated 630Δerm A-B+. The equivalent 513 
mutant in 630E constructed through the insertion of a replication-deficient plasmid, 514 
according to the method of O’Connor et al., 14 was designated 630E A-B+. When ClosTron 515 
technology was used in 630E, this was clarified by adding a ‘CT’ suffix, 630E A-B+CT to the 516 
strain designation. 517 
 518 
Whole genome sequencing and bioinformatics 519 
Genomic DNA from strains 630E A+B-, 630E A+B-CT and 630Δerm A+B- was prepared 520 
by phenol:chloroform extraction. 630E A+B-, 630E A+B-CT, 630Δerm(ΔpyrE) were 521 
sequenced on Ilumina highseq (GATC, Germany) and 630Δerm A+B- on a Roche 454 522 
(Deepseq, Nottingham, UK) and the data compared to the published genome of 630 11,19 523 
using CLC genomic workbench. All raw sequencing data have been deposited in the 524 
sequence read archive (SRA) under the study name PRJNA304508. The accession number is 525 
SRP066836. The sequencing data for 630ΔermΔpyrE had been obtained previously 19 and 526 
with no additional changes, other than the pyrE deletion, present compared to 630Δerm, 527 
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were used to analyse the parental strain 630Δerm. We used a frequency of 70% as a cut-off 528 
for SNP calling. SNPs, InDels and inversions were confirmed by amplifying a few hundred 529 
base pairs up- and downstream of the area of interest (primers are listed in Table S4) and 530 
the amplicon was Sanger sequenced (Source BioScience, UK). This confirmation was done 531 
on all strains including the parental strains (630, 630Δerm, 630E) and the derivatives 532 
(630Δerm A+B-, 630E A+B-, 630E A+B-CT). 533 
 534 
Correction of SNPs and reversal of 150-bp region within the flagellar operon 535 
Using the method described by Cartman et al. 15 we “corrected” the two SNPs and an 536 
inversion in 630E to the 630Δerm genotype. A stretch of DNA corresponding to 537 
approximately 500 bp either side of the area to be altered was synthesised by Biomatik 538 
and cloned into plasmid pMTL-SC7315λ2.3. This vector was transformed by 539 
electroporation into E. coli CA434 cells 36 and subsequently conjugated into 630E. Single 540 
crossover colonies were identified as those growing faster on plates containing 541 
thiamphenicol. Following overnight incubation on CDMM containing 5-fluorocytosine, 542 
colonies were incubated on BHIScc plates with and without thiamphenicol. Those strains 543 
that had lost the plasmid (both wildtype and double crossover) were unable to grow on 544 
thiamphenicol. SNP corrections were confirmed by PCR (Primers see Table S4) and Sanger 545 
sequencing (Source BioScience, UK).   546 
  547 
ClosTron mutagenesis 548 
A tcdB mutant was generated in the 630E background according to the published 549 
method, 16 using the same plasmid that was used to generate the equivalent mutant in 550 
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630∆erm.  9  This newly created strain was referred to as 630E A+B- CT.  551 
 552 
Southern and Western blot 553 
The Southern and Western blot were performed as described in Kuehne et al., 2010. 9 554 
 555 
In vivo testing of mutants 556 
In vivo testing was carried out in Syrian Golden hamsters (Charles River, Germany) as 557 
previously described. 9 Briefly, clindamycin was administered orally on day -five to render 558 
the animals susceptible to infection. On day zero, 10,000 spores were administered orally. 559 
Animals were assessed for signs of CDI (weight loss, wet tail, lethargy, lack of response to 560 
stimulus) six times a day for the first five days, and once daily for the following 14 days. At 561 
this point animals that failed to display signs of CDI were euthanised.  Faecal pellets were 562 
collected daily from day zero to endpoint, homogenised and plated on C. difficile fructose 563 
agar (CDFA). C. difficile colonies were sub-cultured onto BHIS agar and the genotype was 564 
established by PCR (primers in Table S4) followed by Sanger sequencing (results in Table 565 
S2).  At the experimental endpoint, part of the caecum of each animal was collected. This 566 
was also used to plate on CDFA to verify colonisation.   567 
 568 
In vitro testing of mutants 569 
Growth curves: To assess the effects of SNPs and “corrected” SNPs/inversion on the 570 
growth characteristics of all strains, we performed growth curve experiments over 24 h. A 571 
180 μL volume of TY medium was inoculated with 20 μL of an overnight culture in 96-well 572 
plates and incubated for 24 h in a GloMax-Multi Microplate Multimode Reader (Promega, 573 
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USA). Samples were shaken every h and OD600 measurements were taken immediately 574 
after.   575 
Motility assays:  2xYTG (tryptone (1.6%), yeast (1%), NaCl (0.4%), Gelzan (0.24%)[Sigma-576 
Aldrich] and glucose (0.5%)) agar was utilised. 25 mL were poured into each petri dish and 577 
let to solidify at room temperature for 15 min. The plates were then dried at 37°C for 30 578 
min. The plates were placed into the anaerobic cabinet 24 h before use. 2 μL volumes of 579 
overnight culture were ‘dropped’ onto each plate. Plates were incubated anaerobically for 580 
48 h. Motility was assessed by eye and the plates photographed.  581 
Sporulation and germination assays: Sporulation and germination assays were carried out 582 
as previously described. 17, 18  Briefly, for the sporulation assay cultures were grown for five 583 
days, with 2 X 500 µl samples taken at 0, 24, 48, 72, 96 and 120 h. One sample from each 584 
time point was heated to 65°C for 30 min while the other sample was kept at room 585 
temperature. After this time, samples were serially diluted from 100 to 10-7 in PBS. 3 X 20µl 586 
of each dilution was spotted onto BHIS plates containing 0.1% taurocholic acid and were 587 
incubated for 24 h. The following day, colonies were counted and CFU/mL were calculated. 588 
A 630∆erm spo0A::CT mutant strain (containing a ClosTron insertion in the spo0A gene 37), 589 
which is unable to form spores, was used as a negative control.  590 
Germination was measured as a function of the ability of a germinated spore to 591 
outgrow in the absence of taurocholate. Spore stocks were prepared as previously 592 
described by Heeg et al., 2012 38 and stored at -20°C. The optical density of spore 593 
suspensions (OD600) was adjusted to 1.0 and 450 µl was used per measurement. This 594 
equated to approximately 2.5 X 107 spores. Spore suspensions were heat treated at 60°C 595 
for 25 min to kill any remaining vegetative cells and then centrifuged and resuspended in 596 
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BHIS with the germinant taurocholic acid (0.1%) in a total volume of 20 ml. Samples were 597 
taken at 5, 10, 20, 30, 60, 90, 120, 180 and 240 min, briefly centrifuged, washed and 598 
resuspended in phosphate-buffered saline (PBS), the samples were then diluted and plated 599 
on plain BHIS agar. Plates were incubated for 24 h before the CFUs were enumerated.  600 
Colonies that grew on these plates were considered to be germinated vegetative bacteria.   601 
 602 
Toxin A/B ELISA: ELISA assays were performed using the C. DIFFICILE TOX A/B II™ kit from 603 
TechLab and the TGC-E002-1-separate detection of C. difficile toxins A and B kit from 604 
TGCbiomics according to the manufacturers’ instructions. Cultures of C. difficile were 605 
grown in TY medium without glucose for 72 h, at which time 1 ml samples were taken, 606 
centrifuged and the supernatant filter-sterilised and used for the ELISAs. A 1:2 dilution was 607 
used for the toxin B ELISA kit from TGCbiomics.  To quantify toxins a standard curve with 608 
pure toxin (the native antigen company) was established for the TechLab ELISA and also 609 
Toxin A ELISA from TGCbiomics. 610 
 611 
RNAseq: Total RNA was extracted from 2 independent biological replicates of 630, 612 
630∆erm and 630E strains at 3 time points (18 samples). Bacteria were grown in TY broth 613 
medium after 6, 14 and 24 h as previously described. 35  The mRNA was treated with 614 
MicrobExpress kit (Ambion). For oriented RNA-seq library construction, the Truseq 615 
stranded RNA seq Illumina kit was used according to manufacturer’s instructions before 616 
sequencing using the Illumina HiSeq 2500 machine. Sequencing reads were mapped using 617 
Bowtie 39 to the reannotated 630 reference genome 40 complemented with the known 618 
ncRNA. 41  Statistical analyses were performed on each strand coverage count with DESeq2 619 
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42 using the 6 h value as a reference for reporting the expression data of 14 and 24 h. A 620 
gene was considered differentially expressed when the fold change was > 2 and the P value 621 
was < 0.05. 622 
The RNA-seq data discussed in this publication have been deposited in NCBI’s Gene 623 
Expression Omnibus database under the accession no. GSE72006  624 
RNA-seq coverage visualization is available through the COV2HTML software: 43  625 
630 
14H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-20 
24H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-22 
630∆erm 
14H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-24 
24H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-26 
630E 
14H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-28
24H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-30 
 626 
Graphs and statistical analyses 627 
All graphs were generated and statistical analyses were performed using GraphPad 628 
PRISM 6.02. Statistical analysis comprised either 2-way ANOVA for multiple comparisons or 629 
unpaired t test for pairwise comparisons. All experiments were carried out in triplicate 630 
unless stated otherwise. 631 
 632 
Ethics statement 633 
This work was reviewed and approved locally by the Animal Welfare and Ethical 634 
Review Body (formerly the Ethical Review Committee) at the University of Nottingham and 635 
performed under a project licence (PPL 40/3590) granted under the Animal (Scientific 636 
29 
 
Procedures) Act, 1986, by the UK Home Office. The work was performed in accordance 637 
with the NC3Rs ARRIVE guidelines. 44 638 
 639 
Acknowledgement 640 
We would like to thank Haitham Hussain for providing C. difficile 630Δerm, Dena Lyras 641 
for providing C. difficile 630E and toxin mutants and Rory Cave for helping with PCRs and 642 
Sanger sequencing. We would also like to acknowledge Sean Roberts who was involved in 643 
creating the 630E A+B- CT strain. The opinions expressed in this paper are those of the 644 
authors and do not necessarily represent those of Merck Sharp & Dohme Limited or the 645 
Medical Research Council (UK). 646 
 647 
References 648 
1. Govind R, Dupuy B. Secretion of Clostridium difficile toxins A and B requires the 649 
holin-like protein TcdE. PLoS Pathogens 2012; 8:e1002727. 650 
2. Jank T, Giesemann T, Aktories K. Rho-glucosylating Clostridium difficile toxins A and 651 
B: new insights into structure and function. Glycobiology 2007; 17:15R-22R. 652 
3. Sun X, Savidge T, Feng H. The enterotoxicity of Clostridium difficile toxins. Toxins 653 
(Basel) 2010; 2:1848-80. 654 
4. Lyerly DM, Krivan HC, Wilkins TD. Clostridium difficile: its disease and toxins. Clinical 655 
Microbiology Reviews 1988; 1:1-18. 656 
5. Lyerly DM, Barroso LA, Wilkins TD, Depitre C, Corthier G. Characterization of a toxin 657 
A-negative, toxin B-positive strain of Clostridium difficile. Infection Immunity 1992; 658 
60:4633-9. 659 
6. Kim J, Pai H, Seo MR, Kang JO. Clinical and microbiologic characteristics of tcdA-660 
negative variant Clostridium difficile infections. BMC Infectious Diseases 2012; 12:109. 661 
7. Chaves-Olarte E, Low P, Freer E, Norlin T, Weidmann M, von Eichel-Streiber C, 662 
Thelestam M. A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid 663 
between two other large clostridial cytotoxins. Journal of  Biological Chemistry 1999; 664 
274:11046-52. 665 
8. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, 666 
Adams V, Vedantam G, Johnson S, et al. Toxin B is essential for virulence of Clostridium 667 
difficile. Nature 2009; 458:1176-9. 668 
9. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of 669 
toxin A and toxin B in Clostridium difficile infection. Nature 2010; 467:711-3. 670 
30 
 
10. Monot M, Eckert C, Lemire A, Hamiot A, Dubois T, Tessier C, Dumoulard B, Hamel B, 671 
Petit A, Lalande V, et al. Clostridium difficile: New Insights into the Evolution of the 672 
Pathogenicity Locus. Science Reports 2015; 5:15023. 673 
11. Kuehne SA, Cartman ST, Minton NP. Both, toxin A and toxin B, are important in 674 
Clostridium difficile infection. Gut Microbes 2011; 2:252-5. 675 
12. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, Thomson 676 
NR, Roberts AP, Cerdeno-Tarraga AM, Wang H, et al. The multidrug-resistant human 677 
pathogen Clostridium difficile has a highly mobile, mosaic genome. Nature Genetics 2006; 678 
38:779-86. 679 
13. Hussain HA, Roberts AP, Mullany P. Generation of an erythromycin-sensitive 680 
derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the 681 
conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites. 682 
Journal of Medical Microbiology 2005; 54:137-41. 683 
14. O'Connor JR, Lyras D, Farrow KA, Adams V, Powell DR, Hinds J, Cheung JK, Rood JI. 684 
Construction and analysis of chromosomal Clostridium difficile mutants. Molecular 685 
Microbiology 2006; 61:1335-51. 686 
15. Cartman ST, Kelly ML, Heeg D, Heap JT, Minton NP. Precise manipulation of the 687 
Clostridium difficile chromosome reveals a lack of association between the tcdC genotype 688 
and toxin production. Applied and Environmental Microbiology 2012; 78:4683-90. 689 
16. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, Scott JC, Minton NP. The 690 
ClosTron: Mutagenesis in Clostridium refined and streamlined. Journal of Microbiological 691 
Methods 2010; 80:49-55. 692 
17. Burns DA, Heap JT, Minton NP. SleC is essential for germination of Clostridium 693 
difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate. 694 
Journal of Bacteriology 2010; 192:657-64. 695 
18. Burns DA, Heeg D, Cartman ST, Minton NP. Reconsidering the sporulation 696 
characteristics of hypervirulent Clostridium difficile BI/NAP1/027. PLoS One 2011; 697 
6:e24894. 698 
19. Ng YK, Ehsaan M, Philip S, Collery MM, Janoir C, Collignon A, Cartman ST, Minton 699 
NP. Expanding the repertoire of gene tools for precise manipulation of the Clostridium 700 
difficile genome: allelic exchange using pyrE alleles. PLoS One 2013; 8:e56051. 701 
20. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nature 702 
Methods 2012; 9:357-9. 703 
21. Milne I, Stephen G, Bayer M, Cock PJ, Pritchard L, Cardle L, Shaw PD, Marshall D. 704 
Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinform 705 
2013; 14:193-202. 706 
22. Riedel T, Bunk B, Thurmer A, Sproer C, Brzuszkiewicz E, Abt B, Gronow S, Liesegang 707 
H, Daniel R, Overmann J. Genome Resequencing of the Virulent and Multidrug-Resistant 708 
Reference Strain Clostridium difficile 630. Genome Announcements 2015; 3. 709 
23. van Eijk E, Anvar SY, Browne HP, Leung WY, Frank J, Schmitz AM, Roberts AP, Smits 710 
WK. Complete genome sequence of the Clostridium difficile laboratory strain 630Deltaerm 711 
reveals differences from strain 630, including translocation of the mobile element CTn5. 712 
BMC Genomics 2015; 16:31. 713 
24. Rosenbusch KE, Bakker D, Kuijper EJ, Smits WK. C. difficile 630Deltaerm Spo0A 714 
regulates sporulation, but does not contribute to toxin production, by direct high-affinity 715 
binding to target DNA. PLoS One 2012; 7:e48608. 716 
31 
 
25. Ahmed W, Menon S, Godbole AA, Karthik PV, Nagaraja V. Conditional silencing of 717 
topoisomerase I gene of Mycobacterium tuberculosis validates its essentiality for cell 718 
survival. FEMS Microbiology Letters 2014; 353:116-23. 719 
26. Stupina VA, Wang JC. Viability of Escherichia coli topA mutants lacking DNA 720 
topoisomerase I. The Journal of Biological Chemistry 2005; 280:355-60. 721 
27. Suerbaum S, Brauer-Steppkes T, Labigne A, Cameron B, Drlica K. Topoisomerase I of 722 
Helicobacter pylori: juxtaposition with a flagellin gene (flaB) and functional requirement of 723 
a fourth zinc finger motif. Gene 1998; 210:151-61. 724 
28. Tessier MC, Graveline R, Crost C, Desabrais JA, Martin C, Drolet M, Harel J. Effects 725 
of DNA supercoiling and topoisomerases on the expression of genes coding for F165(1), a 726 
P-like fimbriae. FEMS Microbiology Letters 2007; 277:28-36. 727 
29. Ni Bhriain N, Dorman CJ. Isolation and characterization of a topA mutant of Shigella 728 
flexneri. Molecular Microbiology 1993; 7:351-8. 729 
30. Darwin AJ, Miller VL. Identification of Yersinia enterocolitica genes affecting survival 730 
in an animal host using signature-tagged transposon mutagenesis. Molecular Microbiology 731 
1999; 32:51-62. 732 
31. Galan JE, Curtiss R, 3rd. Expression of Salmonella typhimurium genes required for 733 
invasion is regulated by changes in DNA supercoiling. Infection and Immunity 1990; 734 
58:1879-85. 735 
32. Aubry A, Hussack G, Chen W, KuoLee R, Twine SM, Fulton KM, Foote S, Carrillo CD, 736 
Tanha J, Logan SM. Modulation of toxin production by the flagellar regulon in Clostridium 737 
difficile. Infection and Immunity 2012. 738 
33. Baban ST, Kuehne SA, Barketi-Klai A, Cartman ST, Kelly ML, Hardie KR, Kansau I, 739 
Collignon A, Minton NP. The Role of Flagella in Clostridium difficile Pathogenesis: 740 
Comparison between a Non-Epidemic and an Epidemic Strain. PLoS One 2013; 8:e73026. 741 
34. Antunes A, Martin-Verstraete I, Dupuy B. CcpA-mediated repression of Clostridium 742 
difficile toxin gene expression. Molecular Microbiology 2011; 79:882-99. 743 
35. Antunes A, Camiade E, Monot M, Courtois E, Barbut F, Sernova NV, Rodionov DA, 744 
Martin-Verstraete I, Dupuy B. Global transcriptional control by glucose and carbon 745 
regulator CcpA in Clostridium difficile. Nucleic Acids Research 2012; 40:10701-18. 746 
36. Williams DR, Young DI, Young M. Conjugative plasmid transfer from Escherichia coli 747 
to Clostridium acetobutylicum. Journal of General Microbiology 1990; 136:819-26. 748 
37. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP. The ClosTron: a 749 
universal gene knock-out system for the genus Clostridium. Journal of Microbiological 750 
Methods 2007; 70:452-64. 751 
38. Heeg D, Burns DA, Cartman ST, Minton NP. Spores of Clostridium difficile clinical 752 
isolates display a diverse germination response to bile salts. PLoS One 2012; 7:e32381. 753 
39. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient 754 
alignment of short DNA sequences to the human genome. Genome Biology 2009; 10:R25. 755 
40. Monot M, Boursaux-Eude C, Thibonnier M, Vallenet D, Moszer I, Medigue C, 756 
Martin-Verstraete I, Dupuy B. Reannotation of the genome sequence of Clostridium difficile 757 
strain 630. Journal of Medical Microbiology 2011; 60:1193-9. 758 
41. Soutourina OA, Monot M, Boudry P, Saujet L, Pichon C, Sismeiro O, Semenova E, 759 
Severinov K, Le Bouguenec C, Coppee JY, et al. Genome-wide identification of regulatory 760 
RNAs in the human pathogen Clostridium difficile. PLoS Genetics 2013; 9:e1003493. 761 
32 
 
42. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion 762 
for RNA-seq data with DESeq2. Genome Biology 2014; 15:550. 763 
43. Monot M, Orgeur M, Camiade E, Brehier C, Dupuy B. COV2HTML: a visualization 764 
and analysis tool of bacterial next generation sequencing (NGS) data for postgenomics life 765 
scientists. Omics 2014; 18:184-95. 766 
44. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience 767 
research reporting: The ARRIVE guidelines for reporting animal research. Journal of 768 
Pharmacology and Pharmacotherapy 2010; 1:94-9. 769 
 770 
 771 
  772 
33 
 
Figure legends 773 
 774 
Figure 1.  Growth curves of strain 630 and its derivatives. A. 630 (630), 630Δerm and 630E were 775 
grown in TY-broth for 24 h in a 96 well plate reader. The optical density at 600 nm was measured 776 
every 30 min. B. This graph shows the same growth as A. and in addition the growth of derivatives 777 
630Δerm A+B-, 630E A+B- and 630E A+B- CT. 778 
 779 
Figure 2.  Motility assays. The assay was carried out by inoculating overnight cultures onto motility 780 
agar plates and incubating anaerobically for 48 h. Strains 630, 630∆erm and 630E were compared 781 
for their ability to swarm. 782 
 783 
Figure 3.  Sporulation and Germination.  A. Sporulation over 120 h comparing heat treated CFUs of 784 
strains 630, 630∆erm, 630∆erm A+B-, 630E, 630E A+B- and 630E A+B- CT with a non-sporulating 785 
control (spo0A). B. The extent of germination of the indicated strains was measured over 250 min 786 
as the ability of germinated spores to form colonies on plates lacking taurocholate.    787 
 788 
Figure 4.  Toxin ELISAs. A. The C. DIFFICILE TOX A/B II™ ELISA assay kit from TechLab was used to 789 
measure combined toxin A and B in strains 630, 630∆erm, 630∆erm A+B-, 630E, 630E A+B-, 630E 790 
A+B- CT, 630E_topA, 630E_flgB and 630E_CD2667 grown in TY for 72 h. B. and C. Toxin ELISAs 791 
TGCbiomics, measuring the toxins separately were used to quantify toxin A (B) and toxin B (C) 792 
produced by strains 630, 630∆erm, 630∆erm A+B-, 630E, 630E A+B- and 630E A+B- CT grown in TY 793 
for 72 h. Statistics were performed using one-way ANOVA with Fisher’s LSD test. 794 
 795 
Figure 5.  Infection to endpoint in the Hamster infection model.  Groups of Golden Syrian Hamsters 796 
were challenged with C. difficile 630E (5 hamsters), 630E A+B- (11 hamsters) and 630E A+B- CT (6 797 
hamsters). The graph represents the time from inoculation to endpoint. The maximal duration of 798 
the experiment was set to 20 days. Animals represented in open symbols, have not been colonized 799 
despite challenge or lost colonization before day 20. Details can be seen in Table 1. The dotted line 800 
separates this experiment from data obtained by Kuehne et al. 9, which are represented here as a 801 
comparator. In that study 8 hamsters were infected with C. difficile 630Δerm and another 8 802 
hamsters with 630Δerm A+B-. 803 
 804 
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Figure 6. Principal Component Analysis (PCA).  The Principal Component Analysis (PCA) visualizes 805 
the variance of the data in a single graph. The axis represent the two largest variances of the data; 806 
PC1 accounts for 42% and PC2 accounts for 21%, that means that 63% of the total variance of the 807 
dataset is explained in this graph. The third component accounts for less than 10% and further 808 
components have a value that falls rapidly. The PCA represents the RNAseq data (at three different 809 
time points, six, 14 and 24 h) in duplicate for 630 (blue), 630Δerm (green) and 630E (orange). The 810 
different time points are represented as dots in the different shades of the respective colour as 811 
indicated in the colour legend. 812 
 813 
Figure 7. Venn Diagram representing differentially expressed genes in the three different strains. 814 
The diagram summarises the output from the RNAseq data, comparing strains 630, 630Δerm and 815 
630E. It depicts all differentially expressed genes and shows how many genes are differentially 816 
expressed in all strains, in two of the strains or are unique to just one strain.  817 
  818 
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Table 1. Single Nucleotide Polymorphisms (SNPs) and other changes found after re-sequencing.  
 
Gene Description Position 630 12 630 22 630 C F 630Δerm C F 630E C F AA
630E 
CD630_07610 
Putative ATP-dependent RNA 
helicase 
933139 
G - - 
  
- T 
199 100 Asp136Tyr 
CD630_14040 
Putative oligopeptide 
transporter 
1626977 
A - - 
  
- G 
187 100 Glu536Gly 
CD630_20270 
N-carbamoyl-L-amino acid 
hydrolase 
2339506 
G - - 
  
- A 
73 100 Gly373Glu 
CD630_26670 PTSG-BC 3079815 A - -  - C 165 100 *524Glu 
CD630_26270 Hypothetical protein 3034953 C A A   A - 156 100 Gly68Cys 
CD630_33790 
conjugative transposon 
protein 
 
3951559 C - - 
  
- A 
307 100 Glu63Asp 
CD630_12740 topA 1480649 C - -   - T 146 100 Gln386* 
CD630_29430 
Putative phage replication 
protein 
 
3422569 T - - 
  
- C 
 
195 
 
100 Asn210Asp 
IG Intergenic region 309208 - - -   - INV 129 41  
IG Intergenic region 3528736 G - -   - T 94 100  
630Δerm 
CD630_19070 eutG 2209236 G - -   A 127 97    Gly252Glu 
CD630_35650 
GntR family transcriptional 
regulator 4166495 G - -   A 182 100 -   Ala91Val 
IG Intergenic region 2937176 C - -   A 173 100 -    
IG Intergenic region 3005866 T - -   G 156 100 -    
IG Intergenic region 3591103 G - -  A 211 100 -
CD630_12140 spo0A 1413057 - - -   
AGAATGTA
GGAAATAT
AG 112 40 -   Insertion 
CD630_08260 Ferric uptake regulator 1000995 A - - 100 100 G 153 100 - 170 98 Thr41Ala 
630 
CD630_32450 prdR 3797112 C - T 117 100 -   -   Glu261Lys 
36 
 
CD630_02050 
Transcription antiterminator, 
PTS operon regulator 
 
268934 G - T 
 
123 
 
97 -   -   Gly165Cys 
630 and 630Δerm 
CD630_2667 PTSG-BC 3080703 C - T 75 100 T 141 100 -   Val228Ile 
IG Intergenic region 2203033 A - T 105 100 T 174 99     
IG Intergenic region 4007463   C 10 100 C 62 100     
630 and 630Δerm and 630E 
CD630_11900 acyl-CoA N-acyltransferase 1391850 T - C 118 100 C 133 100 C 143 100 Phe133Leu 
CD630_13880 pseudo 1607453 INS 1 - T 119 94 T 175 94 T 124 88 Thr16fs 
Mistake in original sequence 
CD630_17670 gapB 2044514 C G G   G   G    
CD630_31561 pseudo 3686535 INS 1 A A   A   A    
 
 
The table shows the Single Nucleotide Polymorphism (SNP) changes in 630∆erm and 630E compared to the reference 630 12 and also the new annotation by 
Riedel et al (The column ‘Gene’ represents the gene (or intergenic region (IG)) in which the change occurs, the column ‘position’ indicates the exact 
nucleotide position of the change.). 22 It also contains SNP frequency (F) and genomic coverage (C) as well as the resultant amino acid change (AA). No 
change from the original 630 annotation 12 is represented by a dash (-).  
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Table 2.  Strains and plasmids used in this study. 
 
Name Description Source 
Bacterial strains 
E. coli TOP 10 F– mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ (ara 
leu) 7697 galU galK rpsL (StrR) endA1 nupG 
Invitrogen 
E. coli CA434 Conjugation donor Williams et al. 36 
C. difficile 630 Wild-type Brendan Wren 
C. difficile 630Δerm Erythromycin sensitive strain of C. difficile 630 Hussain et al. 13 
C. difficile 
630Δerm(ΔpyrE) 
C. difficile 630Δerm containing a deletion in 
the pyrE gene 
Ng et al. 19 
C. difficile 630E Erythromycin sensitive strain of C. difficile 630 Lyras et al. 8 
C. difficile 630Δerm 
A+B- 
C. difficile 630∆erm tcdB-1511a::intron ermB Kuehne et al. 9 
C. difficile 630E A+B- C. difficile 630E Lyras et al. 8 
C. difficile 630E A+B-
CT 
C. difficile 630E tcdB-1511a:: intron ermB This study 
C. difficile 630E_topA C. difficile 630E This study 
C. difficile 630E_flgB C. difficile 630E This study 
C. difficile 
630E_CD2667 
C. difficile 630E This study 
Plasmids   
pMTL007C-E2:tcdB-
1511a 
ClosTron plasmid containing retargeted region 
to tcdB at IS 1511 (antisense oriented) for C. 
difficile 630∆erm or 630E 
Kuehne et al. 9 
pMTL- pMTL-SC7315λ2.3 containing 1,000 bp This study, based on 
38 
 
SC7315λ2.3::topA homology arms to change nucleotide 1480649 
from T to C in 630E 
Cartman et al. 15 
pMTL-
SC7315λ2.3::flgB 
pMTL-SC7315λ2.3 containing 1,156 bp 
homology arms to reverse the inversion 
upstream of flgB in 630E 
This study, based on 
Cartman et al. 15 
pMTL-
SC7315λ2.3::CD2667 
pMTL-SC7315λ2.3 containing 1,000 bp 
homology arms to change nucleotide 3079815 
from C to A in 630E 
This study, based on 
Cartman et al. 15 
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Supporting Information 
 
Figure S1.  Southern and Western blot of 630E A+B- CT. A. Southern blot showing the single 
ClosTron insertion to create 630E A+B- CT (mutant 1, 2 and 3). The ClosTron plasmid pMTL007C-
E2:tcdB-1511a was used as a positive control and the parental strain 630E as a negative control. 
The probe used binds to the intron insertion.  B. Western blot using an anti-TcdA antibody to 
detect production of toxin A in the supernatant of 630, 630Δerm, 630Δerm A+B-, 630E, 630E A+B- 
and 630E A+B- CT after 96 h. 
 
Table S1.  Genomic and transcriptomic differences between 630, 630Δerm and 630E. 
SNPs, insertions (INS) and inversion (INV) are shown in this table as well as the corresponding 
RNAseq coverage. Changes between 630, 630Δerm and 630E are represented compared to the 
published genome of 630, the new 630 genome by Riedel et al. 22 and also the newly published 
genome of 630Δerm 23. 
 
See attached excel file: S1_Table 
 
Table S2. Colonisation of hamsters with C. difficile strains. 
Colonisation of hamsters with 630E, 630E A+B- and 630E A+B- CT was confirmed by plating faecal 
and caecal samples on CDFA and by extraction genomic DNA and PCR of the toxin A and B genes.  
 
Strain given Colonisation 630 PCR tcdA tcdB Succumbed to CDI 
630E  Caecum + +  
630E Colonised to Day 18 Faecal + +  
630E Colonised to Day 15 Faecal + +
630E  Caecum + + CDI 
630E  Caecum + + CDI 
630EA+B-  Caecum + - CDI 
630EA+B- Not colonised Faecal - -  
630EA+B- Not colonised Faecal - -
630EA+B- Not colonised Faecal - -  
630EA+B- Not colonised Faecal - -  
40 
 
630EA+B-  Caecum + -  
630EA+B-  Caecum + - CDI
630EA+B-  Caecum + -  
630EA+B- Colonised to Day 3 Faecal + -  
630EA+B-  Caecum + -  
630EA+B-  Caecum + -  
630E A+B- CT  Caecum + CT CDI
630E A+B- CT  Caecum + CT CDI 
630E A+B- CT Colonised to Day 15 Faecal + CT  
630E A+B- CT Colonised to Day 18 Faecal + CT  
630E A+B- CT  Caecum + CT  
630E A+B- CT  Caecum + CT
 
Table S3.  Transcriptomic differences between 630, 630Δerm and 630E. 
Differentially expressed (DE) genes, comparing RNAseq data from 6 h to 14 h and 24 h in 630, 
630Δerm and 630E. The genes are classed into cell factor, cell growth, cell wall, fermentation, 
membrane transport, amino acid metabolism, carbon metabolism, cofactor metabolism, lipid 
metabolism, nucleic acid metabolism, mobile elements, motility, operons, regulation, anaerobic 
respiration, secretion, sporulation, stress, translation, unknown and virulence factors. 
Downregulated genes are coloured in green and upregulated genes in red. 
 
See attached excel file: S3_Table 
 
Table S4.  Primers used in this study. 
 
Primer name Sequence (5’-3’) Explanation or SNP 
target (where 
applicable) 
topAMC1 GATGCACAACAGGCAAGAAGAGTGC To screen for 
chromosomal change 
topAMC2b CCCGATTGTAAAACAACTAGACCAATTATG To screen for 
chromosomal change 
flgBMC1b CTATCAAATACAGATGGAAGTTGTGGTG To screen for 
chromosomal change 
flgBMC2c CGAGCATATGATTCTAACGTAGATACATTGAATG To screen for 
chromosomal change 
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CD2667MC1 GTCACCTTATGAGTGAAGTTTGTAATAAATGTGG To screen for 
chromosomal change 
CD2667MC2b GCAAGAGCTGCTGCTGGAAGAC To screen for 
chromosomal change 
JRP3441 8 GTTACCAGGAATACAACCAGAC To test for interrupted 
tcdB 
JRP2839 8 CGGCCAGCCTCGCAGAGCAG To test for interrupted 
tcdB 
JRP3442 8 GCACTTGCTTGATCAAAGCTCC toxA specific PCR, 
positive for all strains 
(630E, 630E A+B-, 630E 
A+B-CT)   
JRP2342 8 CCGGAATTCGCTCTATTGGACTAGACCGTTG toxA specific PCR, 
positive for all strains 
(630E, 630E A+B-, 630E 
A+B-CT)   
Cdi-tcdB-F1 9 TGATAGTATAATGGCTGAAGCTAATGCAGATAATGG To test for tcdB 
ClosTron insertion 
Cdi-tcdB-R1 9 CTTGCATCGTCAAATGACC ATAAGCTAGCC To test for tcdB 
ClosTron insertion 
268934_F TGTCAAGTGAATTAGAAAGAAACCA 268934 
268934_R AAGTGAGCCGTGTTTTGAAAA 268934 
309208_F GCCAGTTGCCAAAAAGAGTC 309208 
309208_R GGCATAGCATCATTTAGTGTTTC 309208 
MCSNP11 CGGGAAAAACAGCTGCTTTTAGTATCCC 933139 
MCSNP12 CCTCTTGCTTGTAAATCTCCTACCAATTC 933139 
10000995_F GATGAAGAAGTTGTTTGGCAAT 1000995 
10000995_R CCTACTTGGCTACACCTTTTACA 1000995 
1391850_F TCTGTCATTTGGAAAGGATGAA 1391850 
1391850_R TCTGTACTTGCTTTTGATATACTTGGA 1391850 
Spo0A_F1 GGCATAGCTAAGGATGGAATTG 1413057 
Spo0A_R1 GGAGTAGAGGAAAAGTTGACACAA 1413057 
1480649_F GCTTCAACAAGAAGGAGCAAA 1480649 
1480649_R TGCTGGTGGTTGTGTAAAATG 1480649 
1607453_F TTGAAGGTGTAAACTCAGTTGTAGG 1607453 
1607453_R TCCAAATAAAAGTCTATGAAAATGAA 1607453 
1626977_F TGGTGGTAGCAAAAACGAAA 1626977 
1626977_R TGCCATTGAATTTGTTGCAG 1626977 
2044514_F CATACTAAATGAGGGGTAAAATAAAGA 2044514 
2044514_R TTTTTCTGCCTTTTCTCTTTGTG 2044514 
MCSNP1 GTTCTGTAATACCTTTTTCTTTAGCTATTTTAATTGC 2203033 
MCSNP2 GTTACCGATATTATAGGCAAAACTGCCC 2203033 
2209236_F CCATTAGTGAGTGATGATTTACTTCC 2209236 
2209236_R GCAAGTTTTGCTATTTCTCTTTCTT 2209236 
2320410_F GTCACTGGTAGGAATTAATCTAACG 2320410 
2320410_R TGCTTTCACAAATGCTTTCG 2320410 
MCSNP13 GAAAGATGAATTTCTATCCATCTTCATCAAATGTGG 2339506 
MCSNP14 GGGGCTGTTGACCTTGGACCC 2339506 
42 
 
MCSNP3 CCTTTGATGTCTAGTTAATTTCTTCACTTATTTTAAGC 2937176 
MCSNP4 GGAAAACCAGCAAAAGCTTGTATTATGATTCCC 2937176 
3005866_F AATATAATTCCCAACCTTCCAAA 3005866 
3005866_R    TTTGTTTGAAGATTAGTGGTGATTG 3005866 
MCSNP5 GTATATTTTTTCTCTAGCTTTATCTCCATCAGGG 3034953 
MCSNP6 GGAAAGGATAAACCAGGTATAGTGGC 3034953 
3079815_F CCCGCTTTTACTTCATCTCC 3079815 
3079815_R GCATCAGAGATTTTGATTGCTTT 3079815 
MCSNP7 CCTGCTACAAATTTTTTCTTTTCTGGC 3080703 
MCSNP8 CTGCTTATCTTTATAAAAAGTTTTATAAAATTGAATTACCTC 3080703 
MCSNP15 CTTCATATTGAGTGAAAGTCTGATTGAAGTTAGC 3422569 
MCSNP16 CTCAACCGTGTGCCGTTTTCCCG 3422569 
3526888_F CTCTTTCCTGCATTCCCAAG 3526888 
3526888_R TTGTTGAGCAGATATAAAATCCCA 3526888 
MCSNP17 CAATCTATTCAAAGATAAACTATAGTACTTCTTCTAC 3528736 
MCSNP18 CCTACTCCTTTAGGTGTGAGATGG 3528736 
3591103_F GGCACTAGCTGCTCCTAATAAA 3591103 
3591103_R   CCATATACCCCTATCCCTCCTT 3591103 
3686535_F TCTTCCAAGCTCTTACCTGTTTG 3686535 
3686535_R GCTCTGTCCAGTTAATTG 3686535 
3797112_F TGCTCCTGTAAATGCACCTG 3797112 
3797112_R CTGTAAAATACAAGTCACTCATTCCAA 3797112 
MCSNP19 CCGTTCCAGACTGTTCAATGCTCC 3951559 
MCSNP20 CCTAAGTAGTAGTTACTGGCAACAGCAC 3951559 
MCSNP9 GCACCCTTAATAACTTGACCAGTTAAAAAGG 4007463 
MCSNP10 CGCCCGAAGCCGATTATCTAACC 4007463 
4166495_F GCATCAAGTAAGTATTTATGCTCTTCA 4166495 
4166495_R TGAACTTGGATAATTACAAGCCATT 4166495 
 








SNP between strains Name
630E
CD630_07610
CD630_14040
CD630_20270
CD630_26670 PTSG-BC
CD630_26270
CD630_33790
CD630_12740 topA
CD630_29430
IG
IG
CD630_20102 (pseudo)
630Δerm
CD630_30360
CD630_19070 eutG
CD630_35650
IG
IG
IG
CD630_12140 spo0A
CD630_08260
CD630
CD630_32450 prdR
CD630_02050
CD630 and 630Δerm
CD630_26670 PTSG-BC
IG
IG
CD630, 630Δerm and 630E
CD630_22630 prsA
CD630_30890
Identical for all strains
CD630_11900
CD630_13880 (pseudo)
Mistake in original sequence
CD630_17670 gapB
CD630_31561 (pseudo)
Product
Putative ATP-dependent RNA helicase
Putative oligopeptide transporter
N-carbamoyl-L-amino acid hydrolase
PTS system, glucose-specific IIBC component
Conserved hypothetical protein 
Putative conjugative transposon protein
DNA topoisomerase I
Putative phage replication protein
Upstream of flgB
-
Fragment of transcriptional regulator
Transporter, Major Facilitator Superfamily (MFS)
Ethanolamine iron-dependent Alcohol dehydrogenase
Transcriptional regulator, GntR family
Upstream of Sodium:glutamate/aspartate symporter fam
Upstream of Lipoprotein signal peptidase
Upstream Transcriptional regulator, GntR family
Stage 0 sporulation protein A
Ferric uptake regulator (perR)
Transcriptional regulator, sigma-54-dependent
Transcription antiterminator, PTS operon regulator
PTS system, glucose-specific IIBC component
Upstream of phage regulator
-
Peptidyl-prolyl cis-trans isomerase, PpiC-type
PTS system, glucose-like IIBC component
Putative acyl-CoA N-acyltransferase
Fragment of transcriptional regulator
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
Fragment of conserved hypothetical protein
Metabolic Pathway (KEEG, Microscope) Position 630 reference
RNA degradation 933,139 G
- 1,626,977 A
Purine metabolism 2,339,506 G
Phosphotransferase system (PTS) 3,079,815 A
- 3,034,953 C
- 3,951,559 C
- 1,480,649 C
- 3,422,569 T
- 309,208 -
- 3,528,736 G
- 2,320,410 A
- 3,526,888 T
Ethanolamine utilization 2,209,236 G
Sporulation 4,166,495 G
- 2,937,176 C
- 3,005,866 T
- 3,591,103 G
Sporulation 1,413,057 INS (18)*
superoxide radicals degradation 1,000,995 A
Proline degradation 3,797,112 C
Phosphotransferase system (PTS) 268,934 G
Phosphotransferase system (PTS) 3,080,703 C
- 2,203,033 A
- 4,007,463 -
- 2,623,495 G
Phosphotransferase system (PTS) 3,590,230 T
- 1,391,850 T
- 1,607,453 INS (1)
Glycolysis / Gluconeogenesis 2,044,514 C
- 3,686,535 INS (1)
630 GenomeA 630 GenomeA 630wt 630∆erm (M) 630E (R) 
Riedel et al Van Eijk et al
- - - - T
- - - - G
- - - - A
- - - - C
A A A A -
- - - - A
- - - - T
- - - - C
- - - - INV (150 bases)
- - - - T
- - - - C
- - - A -
- A - A
- - - - A
- A - A -
- G - G -
- A - A -
- GAATGTAGGAAATAT - GAATGTAGGAAATAT -
- G - G -
- - T - -
- - T - -
- T T T C
- T T T
- - C C -
- - - - T
- - G - -
- C C C C
- T T T T
Complete genome DNA-Seq
G G G G G
A - A A A
- same base as reference
DNA-Seq more than 70%
DNA-Seq less than 70%
630wt 630∆erm (M) 630E (R) 14h / 6h 24h / 6h
G (42) / T (7) G (27) / T (2) T (3) / G (1) 1.00 1.00
A (58) G (46) A (40) G (23) G (3) 1.00 1.00
 G (31) / A (2)  G (27) / A (6) A (15) / G (5) 1.00 1.00
A (88) / C (49) A (80) C (1) 1.00 1.00
A (50) / C (25) A (60) / C (40) C (46) / A (6) 1.00 1.00
C (3) C (1) 4.43 1.00
T (205) / C (136) T (93) / C (24) T (49) / C (1) 1.00 1.00
C (9) / T (2) T (1) C (2) 1.00 3.48
1.00 1.00
1.00 1.00
T (12) 1.00 1.00
G (3) G (2) 1.00 5.91
A (47) / G ( 38) G (17) / A (7) G (5) / A (1) 1.00 1.00
8.34 3.00
1.00 1.00
4.19 1.73
1.00 1.00
G (250) / A (21) G (>1500) / A (300) G (268) / A (250 7.12 1.00
C (3) / T (0) T (3) / C (1) 1.00 1.00
T (1) 0.11 0.02
T (7) T (5) 1.00 1.00
1.00 1.00
1.00 1.00
G (2) G (1) 1.00 1.00
T (140) / G (10) T (45) / G (7) T (24) 1.00 1.00
C (34) C (11) C (5) 1.00 1.00
1.00 1.00
RNA-Seq Mapping (coverage) RNA-Seq* 630wt
G (43) G (8) G (32) 0.26 1.00
1.00 1.00
RNA-Seq mapping = DNA-Seq Difference ex
RNA-Seq mapping ≠ DNA-Seq INV 150 bp invers
*RNA-Seq FC >= 3, IG: gene expression after the mutation INS (18)* Identical in 63
14h / 6h 24h / 6h 14h / 6h 24h / 6h Comments
1.00 1.00 0.12 1.00 OK
1.00 1.00 1.00 0.27 OK
1.00 1.00 1.00 3.13 OK
0.05 0.03 0.32 0.01 OK
1.00 1.00 1.00 1.00 OK
4.5 1.00 5.28 1.00 RNA-Seq ≠ DNA-Seq
1.00 4.47 1.00 1.00 RNA-Seq ≠ DNA-Seq
1.00 1.00 1.00 5.10 OK with CD630wt
1.00 1.00 1.00 1.00 No expression
1.00 1.00 1.00 1.00 CD630_20101|ermC
1.00 1.00 1.00 1.00 Low expression
1.00 1.00 1.00 1.00 RNA-Seq ≠ DNA-Seq
1.00 1.00 1.00 1.00 RNA-Seq ≠ DNA-Seq
7.35 5.68 5.03 3.39 No expression
1.00 1.00 1.00 1.00 No expression
1.00 3.00 1.00 1.00 Gene after : CD630_30900|TreR
1.00 1.00 0.17 0.23 No expression
10.45 1.00 5.42 1.00 RNA-Seq ≠ DNA-Seq
1.00 1.00 1.00 1.00 RNA-Seq ≠ DNA-Seq
0.04 0.08 0.01 0.01 Low expression
0.05 0.03 0.32 0.01 OK
1.00 1.00 1.00 1.00 No expression
1.00 1.00 1.00 1.00 No expression
1.00 1.00 1.00 1.00 RNA-Seq ≠ DNA-Seq
1.00 13.07 1.00 7.38 RNA-Seq ≠ DNA-Seq
1.00 1.00 1.00 1.00 OK
1.00 1.00 1.00 1.00 No expression
RNA-Seq* 630∆erm (M) RNA-Seq* 630E (R) 
1.00 1.00 1.00 3.54 OK
1.00 1.00 1.00 1.00 No expression
pression in agreement with SNP
sion promoter region of flgB
30 GenomeA and 630E (R) strains


Class Gene ID Name Product 630 14H / 6H 630 24H / 6H
Cell Factor CD630_05240 Putative peptidase, M20 family 1 0.23
Cell Factor CD630_06490 Putative peptidase, S9 family 1 5.88
Cell Factor CD630_06500 Putative peptidase, S9 family 1 6.92
Cell Factor CD630_07300 Putative iron-sulfur protein 1 0.32
Cell Factor CD630_07310 Putative radical SAM superfamily protein 1 0.33
Cell Factor CD630_07320 Putative radical SAM superfamily protein 1 0.28
Cell Factor CD630_07330 Putative biotin/lipoate-protein ligase 1 0.31
Cell Factor CD630_12770 Putative acetyltransferase 1 3.08
Cell Factor CD630_15600 Conserved hypothetical protein 1 4.52
Cell Factor CD630_15610 Putative dehydrogenase 1 4.13
Cell Factor CD630_15620 Conserved hypothetical protein 1 3.73
Cell Factor CD630_16760pcp Pyrrolidone-carboxylate peptidase 1 4.96
Cell Factor CD630_17650 Putative hydrolase, NUDIX family 1 0.3
Cell Factor CD630_21540 Putative ATP/GTP-binding protein 1 3.85
Cell Factor CD630_21550bioB Biotin synthase 1 3.97
Cell Factor CD630_21560thiH Thiamine biosynthesis protein ThiH 1 6.94
Cell Factor CD630_22130cynT Carbonic anhydrase 1 0.29
Cell Factor CD630_28550 Putative NAD(P)-binding oxidoreductase 1 0.25
Cell Factor CD630_30090 Putative pyridine nucleotide-disulphide oxidoreductase, class I 1 3.86
Cell Wall CD630_02410 Phosphate-threonine kinase 1 0.03
Cell Wall CD630_02420 Phosphothreonine N-acetylglucosamine catalysis 1 0.04
Cell Wall CD630_02430 Methyltransferase 1 0.04
Cell Wall CD630_02440 Putative CDP-glycerol:Poly(glycerophosphate) glycerophosphotransferase 1 0.06
Cell Wall CD630_03060 Conserved hypothetical protein 1 4.61
Cell Wall CD630_07860 Putative membrane protein 1 4.33
Cell Wall CD630_08300 Putative membrane protein 1 5.7
Cell Wall CD630_10290 Putative cell wall anchored protein 1 8.05
Cell Wall CD630_10330mnaA UDP-N-acetylglucosamine 2-epimerase (UDP-GlcNAc-2-epimerase) 1 4.23
Cell Wall CD630_10360cwp16 Putative N-acetylmuramoyl-L-alanine amidase, autolysin 1 0.33
Cell Wall CD630_15850 Putative N-acetylglucosamine kinase NAGK-like 1 4.51
Cell Wall CD630_16450 Putative membrane protein 1 0.25
Cell Wall CD630_16460 Putative peptidase, M19 family 1 0.23
Cell Wall CD630_34580 Putative membrane protein 1 0.21
Fermentation CD630_10540bcd2 Butyryl-CoA dehydrogenase 1 0.27
Fermentation CD630_10550etfB Electron transfer flavoproteins subunit beta 1 0.25
Fermentation CD630_10560etfA Electron transfer flavoprotein subunit alpha 1 0.28
Fermentation CD630_10570crt2 3-hydroxybutyryl-CoA dehydratase (Crotonase) 1 0.31
Fermentation CD630_29660adhE Aldehyde-alcohol dehydrogenase 1 8.74
Membrane Transport CD630_01610 ABC-type transport system, multidrug-family ATP-binding protein 0.31 0.25
Membrane Transport CD630_01620 Putative radical SAM-family protein 0.33 0.26
Membrane Transport CD630_04930 PTS system, mannose/fructose/sorbose IIC component 1 0.32
Membrane Transport CD630_06450 ABC-type transport system, lantibiotic/multidrug-family ATP-binding protein 1 0.28
Membrane Transport CD630_07660srlEb PTS system, sorbitol-specific IIB C-terminal component (Glucitol) 1 0.32
Membrane Transport CD630_08540oppC ABC-type transport system, oligopeptide-family permease 1 0.32
Membrane Transport CD630_08550oppA ABC-type transport system, oligopeptide-family extracellular solute-binding protein 1 0.27
Membrane Transport CD630_12670 ABC-type transport system, multidrug-family permease 1 3.77
Membrane Transport CD630_12680 ABC-type transport system, multidrug-family ATP-binding protein 1 4.87
Membrane Transport CD630_14840ssuA ABC-type transport system, alkanesulfonates-family extracellular solute-binding protein 1 0.33
Membrane Transport CD630_15230 Putative transporter 1 3.3
Membrane Transport CD630_17160 Putative permease 1 0.16
Membrane Transport CD630_21020 Putative Na(+)/H(+) antiporter 1 3.04
Membrane Transport CD630_21070 Xanthine/uracil/thiamine/ascorbate permease family protein 1 3.62
Membrane Transport CD630_24880 PTS system, fructose-like IIA component 1 3.25
Membrane Transport CD630_24890 Transcription antiterminator, PTS operon regulator 1 4.99
Membrane Transport CD630_28700kdgT1 2-keto-3-deoxygluconate permease 1 1 0.28
Membrane Transport CD630_28830celB PTS system, cellobiose-specific IIC component 1 0.21
Membrane Transport CD630_28840celA PTS system, cellobiose-specific IIB component 1 0.29
Membrane Transport CD630_30120 Putative alpha-mannosidase 0.3 1
Membrane Transport CD630_30130 PTS system, mannose-specfic IIC component 0.29 0.3
Membrane Transport CD630_30140 PTS system, mannose-specfic IIB component 0.3 0.29
Membrane Transport CD630_30150 PTS system, mannose-specfic IIA component 0.31 1
Membrane Transport CD630_30160 Transcription antiterminator, PTS operon regulator 0.31 1
Membrane Transport CD630_30760tagK Tagatose-6-phosphate kinase 1 0.24
Membrane Transport CD630_34410 Putative pyridoxal phosphate-dependent transferase (PLP-dependent transferase) 1 3.83
Membrane Transport CD630_34420 Putative peptidase, M24 family 1 3.97
Membrane Transport CD630_34430 PTS system, lactose/cellobiose-family IIC component 1 4.22
Membrane Transport CD630_34450 PTS system, lactose/cellobiose-family IIA component 1 3.67
Membrane Transport CD630_35250 ABC-type transport system, iron-family extracellular solute-binding protein 1 0.09
Membrane Transport CD630_35260 ABC-type transport system, iron-family permease 1 0.06
Membrane Transport CD630_35270 ABC-type transport system, iron-family ATP-binding protein 1 0.07
Metabolism Amino Acid CD630_03050 Putative glutamate carboxypeptidase 1 4.01
Metabolism Amino Acid CD630_14810 Putative tryptophan RNA-binding attenuation protein 1 0.31
Metabolism Amino Acid CD630_15470hisZ ATP phosphoribosyltransferase regulatory subunit 1 0.23
Metabolism Amino Acid CD630_15480hisG ATP phosphoribosyltransferase (ATP-PRTase) (ATP-PRT) 1 0.09
Metabolism Amino Acid CD630_15490hisC Histidinol-phosphate aminotransferase (Imidazole acetol-phosphate transaminase) 1 0.17
Metabolism Amino Acid CD630_15500hisB Imidazoleglycerol-phosphate dehydratase 1 0.18
Metabolism Amino Acid CD630_15510hisH Imidazole glycerol phosphate synthase subunit HisH 1 0.15
Metabolism Amino Acid CD630_15520hisA 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide iso 1 0.17
Metabolism Amino Acid CD630_15530hisF Imidazole glycerol phosphate synthase subunit HisF 1 0.12
Metabolism Amino Acid CD630_15540hisI Histidine biosynthesis bifunctional protein HisIE [Includes: Phosphoribosyl-AMP cyclohydrolase  Ph 1 0.2
Metabolism Amino Acid CD630_15800hom2 Homoserine dehydrogenase 1 4.73
Metabolism Amino Acid CD630_17640 Putative phenylalanyl-tRNA synthetase beta chain 1 0.28
Metabolism Amino Acid CD630_20530lysA Diaminopimelate decarboxylase 1 0.27
Metabolism Amino Acid CD630_20540lysC Aspartokinase 1 0.25
Metabolism Amino Acid CD630_21180thrC Threonine synthase 1 3.35
Metabolism Amino Acid CD630_22520 Glutamate 2,3-aminomutase 1 3.08
Metabolism Amino Acid CD630_25020 Putative pyridoxal phosphate-dependent transferase 1 0.17
Metabolism Amino Acid CD630_30990 Putative amidohydrolase, M20D family 0.31 0.04
Metabolism Amino Acid CD630_31000 Putative C4-dicarboxylate anaerobic carrier, DcuC family 0.33 0.03
Metabolism Carbon CD630_23870 Alpha-hydroxy acid dehydrogenase, FMN-dependent 1 0.17
Metabolism Carbon CD630_24100ppdK Pyruvate phosphate dikinase (ATP:pyruvate, phosphate phosphotransferase) 0.31 1
Metabolism Carbon CD630_28130garR Tartronate semialdehyde reductase 1 0.24
Metabolism Carbon CD630_36410 Conserved hypothetical protein 1 0.21
Metabolism Cofactor CD630_21690 Putative iron-sulfur binding protein 0.32 0.21
Metabolism Lipids CD630_19070eutG Ethanolamine iron-dependent Alcohol dehydrogenase 1 5.91
Metabolism Lipids CD630_19080eutS Ethanolamine carboxysome structural protein, BMC family 1 3.56
Metabolism Lipids CD630_19090eutP Ethanolamine utilization protein, GTPase family 1 3.1
Metabolism Lipids CD630_19120eutA Ethanolamine reactivating factor for ammonia lyase eutBC 1 15.98
Metabolism Lipids CD630_19130eutB Ethanolamine ammonia lyase large subunit 1 12.31
Metabolism Lipids CD630_19140eutC Ethanolamine ammonia lyase small subunit 1 20.98
Metabolism Lipids CD630_19150eutL Ethanolamine carboxysome structural protein, BMC family 1 17.38
Metabolism Lipids CD630_19160eutK Ethanolamine carboxysome structural protein, BMC family 1 21.53
Metabolism Lipids CD630_19170eutE Ethanolamine acetaldehyde oxydoreductase 1 15.88
Metabolism Lipids CD630_19180eutM Ethanolamine carboxysome structural protein, BMC family 1 14.47
Metabolism Lipids CD630_19190eutT Ethanolamine corrinoid cobalamin adenosyltransferase 1 17.74
Metabolism Lipids CD630_19200eutD Putative phosphotransacetylase 1 22.6
Metabolism Lipids CD630_19210 Putative ethanolamine utilization protein 1 11.57
Metabolism Lipids CD630_19220eutN Ethanolamine carboxysome structural protein, BMC family 1 6.32
Metabolism Lipids CD630_19230 Ethanolamine carboxysome structural protein, BMC family 1 12.09
Metabolism Lipids CD630_19240eutH Ethanolamine transport protein 1 17.73
Metabolism Lipids CD630_19250eutQ Ethanolamine utilization protein, Cupin barrels family 1 11.59
Metabolism Nucleic Acid CD630_06260 Putative replicative helicase DnaB-like 1 7.06
Metabolism Nucleic Acid CD630_12720 Putative magnesium chelatase 1 4.53
Metabolism Nucleic Acid CD630_12760 Putative replication-associated recombination protein A RarA 1 3.08
Metabolism Nucleic Acid CD630_20730xdhA Xanthine dehydrogenase, molybdenum binding subunit 1 3.31
Metabolism Nucleic Acid CD630_24750 Putative membrane protein 1 3.09
Metabolism Nucleic Acid CD630_25230 Putative hydrolase 1 0.31
Metabolism Nucleic Acid CD630_25240nadD Nicotinate-nucleotide adenylyltransferase 1 0.25
Metabolism Nucleic Acid CD630_36420 Putative selenocysteine synthase 1 0.24
Metabolism Nucleic Acid CD630_36430 Dihydroorotase 1 0.31
Mobile Element CD630_03730 Putative membrane protein Tn916-like, CTn1-Orf18 3.14 1
Mobile Element CD630_04260 Putative conjugative transposon protein Tn1549-like, CTn2-Orf21 1 0.28
Mobile Element CD630_05101 Putative conjugative transposon protein Tn5397, CTn3-Orf8 1 0.22
Mobile Element CD630_06250 Putative phage protein 1 8.03
Mobile Element CD630_09200 Putative phage protein 1 3.1
Mobile Element CD630_09380 Putative phage protein 1 3.16
Mobile Element CD630_13630 Putative phage XkdK-like protein 1 3.16
Mobile Element CD630_13640 Putative phage XkdM-like protein 1 3.88
Mobile Element CD630_13650 Putative phage XkdN-like protein 1 4.87
Mobile Element CD630_29290 Putative phage protein 1 3.16
Mobile Element CD630_29320 Conserved hypothetical protein 1 3.76
Mobile Element CD630_29340 Putative phage protein 1 3.1
Mobile Element CD630_29370 Putative phage protein 1 3.39
Mobile Element CD630_29390 Putative phage protein 1 4.13
Mobile Element CD630_33800 Putative cell wall hydrolase Tn916-like, CTn1-Orf17 3.48 1
Mobility CD630_02280fliN Flagellar motor switch protein FliN 1 0.24
Mobility CD630_02330fliW Flagellar assembly factor FliW 1 0.03
OPERONS (Automatic) CD630_17340 Conserved hypothetical protein 1 3.11
OPERONS (Automatic) CD630_17600 Putative iron-sulfur protein 1 0.27
OPERONS (Automatic) CD630_18690 Putative endonuclease relaxase Tn1549-like, CTn2-Orf20 1 0.33
OPERONS (Automatic) CD630_23970 Putative exonuclease 1 3.11
OPERONS (Automatic) CD630_35580birA BirA bifunctional protein [Includes: biotin operon repressor and biotin--[acetyl-CoA-carboxylase] sy 1 3.51
OPERONS (Automatic) CD630_35750 Putative sodium:solute symporter 1 3.16
Regulations CD630_02920 Transcriptional regulator, HTH-type 1 3.99
Regulations CD630_06170 Putative membrane protein 1 0.18
Regulations CD630_06270 Putative transcriptional regulator, activator Mor 1 5.63
Regulations CD630_12690 Two-component response regulator 1 3.33
Regulations CD630_12700 Two-component sensor histidine kinase 1 4.35
Regulations CD630_17250 Transcriptional regulator, AraC family 1 3.49
Regulations CD630_18410 Two-component sensor histidine kinase 3.26 1
Regulations CD630_23850 Putative diguanylate cyclase signaling protein 1 4.63
Regulations CD630_32610pstB ABC-type transport system, phosphate-specific ATP-binding 1 4.23
Respiration Anaerobic CD630_34760atpZ ATP synthase transporter protein AtpZ 1 4.24
Sporulation CD630_12130spoIVB Stage IV sporulation protein B, peptidase S55 family 1 3.68
Stress CD630_03440 Putative beta-lactamase-like protein 1 3.21
Stress CD630_13740 Putative beta-lactamase-inhibitor protein II 1 3.54
Stress CD630_16250vanS Two-component sensor histidine kinase 1 3.01
UNKNOWN CD630_11560 Conserved hypothetical protein 1 0.02
UNKNOWN CD630_15830 Conserved hypothetical protein 1 4.18
UNKNOWN CD630_15831 Conserved hypothetical protein 1 4.21
UNKNOWN CD630_17170 Conserved hypothetical protein, DUF917 family 1 0.18
UNKNOWN CD630_17730 Conserved hypothetical protein 1 4.2
UNKNOWN CD630_20620 Conserved hypothetical protein 1 3.12
UNKNOWN CD630_21570 Conserved hypothetical protein 1 5.84
UNKNOWN CD630_22590 Conserved hypothetical protein with RmlC-like jelly roll fold 1 0.28
UNKNOWN CD630_23860 Conserved hypothetical protein 1 3.59
UNKNOWN CD630_24200 Conserved hypothetical protein 1 0.28
UNKNOWN CD630_28790 Conserved hypothetical protein 1 0.29
UNKNOWN CD630_30220 Conserved hypothetical protein 1 3.28
UNKNOWN CD630_30430 Conserved hypothetical protein 1 0.04
UNKNOWN CD630_33230 Conserved hypothetical protein 1 3.04
UNKNOWN CD630_33240 Conserved hypothetical protein 1 3.95
UNKNOWN CD630_35512 Conserved hypothetical protein 1 3.3
Virulence Factors CD630_06640tcdC Negative regulator of toxin gene expression 1 0.16
